Clinical Trials Logo

Filter by:
NCT ID: NCT04863937 Completed - Clinical trials for Neuromuscular Control

Distal Thigh Compression Garment Improves Knee Control and Safety Perceptions During Single Leg Triple Hop for Distance

Start date: March 26, 2018
Phase: N/A
Study type: Interventional

This study measured knee frontal plane projection angle (FPPA) and sports safety and performance perceptions of female athletes during a single leg triple hop for distance for 3 conditions (standard knee sleeve, no device and distal thigh compression garment (DTCG)). The hypothesis was that the DTCG group would display superior dynamic knee valgus FPPA compared to the standard knee sleeve and no device groups.

NCT ID: NCT04863287 Completed - Lyme Disease Clinical Trials

First Clinical Study of the Safety and Blood Levels of a Human Monoclonal Antibody (2217LS) Against Lyme Disease Bacteria in Healthy People

Start date: February 11, 2021
Phase: Phase 1
Study type: Interventional

This is a research study of the investigational drug 2217LS in healthy volunteers. Investigational means 2217LS is a new drug that has not been approved for the treatment of any disease. 2217LS is human antibody designed to provide protection from Lyme disease. Lyme disease is a disease carried by infected ticks and can cause the infection to spread to the joints, heart and nervous system in humans. This is the first time 2217LS will be given to humans. This is not a study of how well 2217LS works against Lyme disease. The only purposes of this study are to: 1) Learn about the safety and tolerability of a subcutaneous (SC [under the skin]) injection of 2217LS when administered to healthy volunteers. 2) Find out how much 2217LS is in the blood of healthy volunteers after receiving 2217LS SC. In this study, groups of healthy volunteers will be given different doses of 2217LS by SC injection. Volunteers will stay in the study unit for a total of 4 overnights. The planned duration of participation is up to 14 months. Study personnel will monitor their safety using standard procedures like physical examinations, electrocardiograms, questions about possible side effects, blood and urine tests. The amount of 2217LS in their blood will also be measured.

NCT ID: NCT04863261 Completed - HIV Infections Clinical Trials

Cabenuva Injection Tracking in CHORUS

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

This is a cluster randomized trial in which clinics will be randomized to the intervention or the control arm. The purpose of this study is to assess if receiving alerts can help providers manage the scheduling of monthly cabotegravir + rilpivirine long-acting injections for the treatment of HIV.

NCT ID: NCT04863157 Completed - Insomnia Clinical Trials

Survivor-Sleep Health Information Program

Start date: May 24, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to learn if an educational program delivered to parents/guardians can help improve the sleep of children experiencing sleep problems after completing cancer treatment. The name of the intervention is Survivor-SHIP (Sleep Health Information Program).

NCT ID: NCT04862741 Completed - Ulcerative Colitis Clinical Trials

Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis

Start date: May 5, 2021
Phase: Phase 1
Study type: Interventional

This is a Phase 1b, randomized, double-blind, multicenter dose-ranging study to evaluate the safety, tolerability, and PK of NX-13. Approximately 40 subjects will be randomized in a 3:3:3:1 ratio to receive 1 of 3 NX-13 treatment regimens (NX-13 250 mg IR, 500 mg IR, 500 mg MR) (12 evaluable subjects at each of the 3 dose levels) or placebo (4 subjects), once daily for 28 consecutive days.

NCT ID: NCT04862689 Completed - Coronary Stenosis Clinical Trials

Investigation of the Ringer Perfusion Balloon Catheter (Ringer PTCA)

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to demonstrate safe and effective use of the Ringer perfusion balloon catheter for dilatation/pre-dilatation of coronary stenoses during percutaneous coronary intervention (PCI).

NCT ID: NCT04862624 Completed - Depression, Anxiety Clinical Trials

Media Project and Health Study - Spanish Version

Start date: November 16, 2020
Phase: N/A
Study type: Interventional

We seek to test the efficacy of the Spanish version of the "Catalina" web-app intervention compared to an attention control web-app in reducing symptoms of depression and/or anxiety and motivate women to take action to get help.

NCT ID: NCT04862312 Completed - Malnutrition Clinical Trials

Video Chat During Meals to Improve Nutritional Intake in Older Adults

VideoDining
Start date: March 31, 2021
Phase: N/A
Study type: Interventional

The VideoDining study is a Stage IB behavioral intervention development project. The objectives are to determine the feasibility and acceptability of using video chat during mealtimes (VideoDining) in community-dwelling older adults eating alone at home and to evaluate changes in nutritional intake and loneliness in response to VideoDining.

NCT ID: NCT04862208 Completed - Satiety Clinical Trials

Breakfast Consumption and Energy Balance in Active Adult Males

Start date: May 6, 2021
Phase: N/A
Study type: Interventional

Exercising in the fasted state results in greater fat oxidation during exercise and results in decreased caloric intake in the meals after exercise. However, the studies that examine fasted vs. fed exercise utilize a carbohydrate-based breakfast, which can increase blood glucose and insulin concentrations, which is considered a negative consequence. A protein breakfast, which can increase satiety and rest of day energy intake could also increase resting energy expenditure as well as fat oxidation during exercise. However, comparisons between fasting exercise and pre-exercise breakfast macronutrient intake (i.e., carbohydrate vs. protein) have not been made. Therefore the purpose of this study is to investigate if eating breakfast and the composition of this breakfast before exercise has an effect on the food eaten throughout the rest of the day.

NCT ID: NCT04862065 Completed - Healthy Clinical Trials

Alinity s Anti-HCV II - Clinical Evaluation Protocol

Start date: April 19, 2021
Phase: N/A
Study type: Interventional

The objective of this study is to demonstrate the performance and intended use of the Alinity s Anti-HCV II investigational assay in a donor screening environment using clinical samples to evaluate assay performance. The Alinity s Anti-HCV II assay performance will be evaluated utilizing the Food and Drug Administration (FDA) licensed Alinity s Anti-HCV assay as the comparator method. The data will be used to support regulatory submissions and/or publications.